← Back to Guidelines

2013 AHA/ACC Guideline on Lifestyle Management

Evidence-based recommendations for dietary patterns, physical activity, and behavioral strategies to reduce cardiovascular risk

Published: Journal of the American College of Cardiology (2014) Vol. 63, No. 25, pp. 2960–2984
DOI: 10.1016/j.jacc.2013.11.003

View Original PDF

Summary Framework Diet Patterns LDL Cholesterol Blood Pressure Physical Activity Key Recommendations Risk Calculators

Summary

The 2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk provides comprehensive, evidence-based recommendations for dietary patterns, physical activity, and behavioral modifications to reduce cardiovascular disease risk. This guideline emphasizes dietary patterns (particularly Mediterranean and DASH patterns) over individual food components, advocates for sodium reduction and physical activity, and integrates lifestyle interventions as foundational therapy for cardiovascular risk reduction.

Guideline Scope

Population: Adults without and with cardiovascular disease at all risk levels
Focus: Lifestyle modifications as primary and adjunctive therapy
Key Outcomes: Blood pressure reduction, lipid profile improvement, CVD prevention
Evidence Base: Randomized controlled trials and meta-analyses from 1998–2009
Classification: Uses ACC/AHA Class of Recommendation (I, IIa, IIb, III) and Level of Evidence (A, B, C)

Guideline Framework & Classification

This guideline uses a Critical Questions (CQ) based approach to structure recommendations around three key clinical areas: dietary patterns and macronutrients, sodium and potassium intake, and physical activity. Each recommendation is classified by strength and evidence level.

Class of Recommendation & Evidence Levels

Strength of Recommendation (COR):

Class I: Strongly recommended; benefit >> risk. Procedure/treatment should be administered.
Class IIa: Reasonable to perform; benefit >> risk. Procedure/treatment can be useful and effective.
Class IIb: May be considered; benefit ≈ risk. Procedure/treatment may be considered.
Class III: Not recommended; risk ≥ benefit. Procedure/treatment is not useful/effective and may be harmful.

Level of Evidence (LOE):

Level A: High quality populations evaluated. Multiple RCTs or meta-analyses.
Level B: Limited populations evaluated. Some conflicting evidence from single RCT or nonrandomized trial.
Level C: Very limited populations evaluated. Only consensus opinion, case studies, or standard of care.

Critical Questions Addressed

This guideline systematically evaluates three key clinical domains:

CQ1: What is the effect of dietary patterns and/or macronutrient composition on CVD risk factors (LDL-C, BP) when compared with no treatment or other types of interventions?
CQ2: Among adults, what is the effect of dietary intake of sodium and potassium on CVD risk factors and outcomes when compared with no treatment or other types of interventions?
CQ3: Among adults, what is the effect of physical activity on BP and lipids when compared with no treatment or other types of interventions?

Dietary Patterns & Macronutrients

The guideline emphasizes dietary patterns over individual components. Two patterns have the strongest evidence: the Mediterranean (MED) pattern and the DASH (Dietary Approaches to Stop Hypertension) pattern. Both improve blood pressure and lipid profiles.

Recommended Dietary Pattern

Class I Recommendation: Cardiovascular-Protective Diet

Emphasize: Vegetables, fruits, whole grains, low-fat dairy, poultry, fish, legumes, nontropical vegetable oils, and nuts
Limit: Sweets, sugar-sweetened beverages, and red meats
Adaptation: Tailor to individual calorie needs, cultural preferences, and comorbidity management (e.g., diabetes)
Implementation: Use DASH dietary pattern, USDA Food Pattern, or AHA Diet guidelines
Level of Evidence: Level A

Evidence Summary for Dietary Patterns

Dietary Pattern	BP Effect	LDL-C Effect	COR / LOE
DASH Pattern Emphasizes vegetables, fruits, whole grains, low-fat dairy, fish, legumes	Systolic 5–6 mm Hg reduction Diastolic 3 mm Hg reduction	LDL-C reduction 11 mg/dL	1 / A
Mediterranean Pattern High vegetables, fruits, olive oil, fish, moderate wine	Systolic 2–3 mm Hg reduction Diastolic 1–2 mm Hg reduction	Modest LDL-C reduction	2b / B
DASH + Lower Sodium DASH pattern combined with sodium reduction	Additive effect: greater BP reduction than either intervention alone	LDL-C and lipid improvement	1 / A

Saturated Fat & Trans Fat Reduction

Saturated Fat Goals

Target: 5%–6% of total daily calories
Reduces LDL-C by 5–10 mg/dL
Class I: Level A

Trans Fat Elimination

Minimize intake from processed foods
Avoid partially hydrogenated oils
Class I: Level A

Dietary Fat and Cholesterol Effects

Saturated Fat Substitution: For every 1% energy from saturated fat replaced with carbohydrate, LDL-C is lowered by approximately 1.3 mg/dL. IIa / B

Figure 7: Evidence for Dietary Fat and Cholesterol Effects

LDL Cholesterol Lowering Through Diet

Dietary pattern modification is the foundation for LDL-C reduction. Combined changes in diet composition (saturated fat, trans fat, plant stanols/sterols) can achieve 20–30% reduction in LDL-C.

Key LDL-C Lowering Strategies

Overall dietary pattern: Mediterranean or DASH pattern (Class I, Level A)
Saturated fat: Reduce to 5%–6% of calories (Class I, Level A)
Trans fat: Minimize from processed foods (Class I, Level A)
Plant sterols/stanols: 2 g/day reduces LDL-C ~6% (supportive evidence)
Soluble fiber: Oat bran, barley, beans, apples (supportive evidence)

Blood Pressure Reduction Through Lifestyle

Both dietary pattern and sodium reduction are Class I, Level A recommendations for blood pressure lowering. Combined interventions produce additive effects on BP reduction.

Sodium Intake Recommendations

Recommended Sodium Levels

Target: ≤2,400 mg/day (Class I, Level A)
Optimal: 1,500 mg/day for greater BP reduction (Class IIa, Level B)
Minimum: Reduce by ≥1,000 mg/day (Class I, Level A)
BP reduction: ~2–8 mm Hg per 1,000 mg reduction

Combined DASH + Sodium Reduction

Additive BP-lowering effects
DASH alone: 8–14 mm Hg SBP reduction
+ Sodium reduction: Additional 5–6 mm Hg reduction
Class I: Level A

Physical Activity for Cardiovascular Health

Aerobic physical activity reduces both LDL cholesterol and blood pressure. The guideline recommends 3–4 sessions per week of moderate- to vigorous-intensity activity lasting ~40 minutes per session. This aligns with 150 minutes of moderate-intensity activity per week (federal guidelines).

Physical Activity Recommendations Summary

For LDL-C Reduction

Frequency: 3–4 sessions/week
Duration: ~40 minutes/session
Intensity: Moderate to vigorous
Outcome: LDL-C ↓, HDL-C ↑, triglycerides ↓
Evidence: Class IIa, Level A

For Blood Pressure Reduction

Frequency: 3–4 sessions/week
Duration: ~40 minutes/session
Intensity: Moderate to vigorous aerobic
BP Reduction: 2–5 mm Hg SBP, 1–4 mm Hg DBP
Evidence: Class IIa, Level A

Types of Aerobic Activity

Brisk walking: 3–5 mph, on flat terrain or mild slopes
Jogging/running: 5–8 mph, tailored to fitness level
Cycling: Stationary or outdoor, moderate resistance
Swimming: Continuous laps, moderate-to-vigorous pace
Group fitness: Aerobic classes, dance, group running
Sports: Basketball, tennis, soccer (intermittent activity acceptable)

Aerobic Exercise Effects on Cardiovascular Risk Factors

Lipid Effects: Aerobic exercise reduces LDL-C by 3–6 mg/dL and non-HDL-C by 6 mg/dL on average. IIa / A

BP Effects: Aerobic exercise reduces both systolic and diastolic BP, with greater reductions in those with prehypertension or hypertension. IIa / A

Intensity: Moderate-to-vigorous intensity (50–85% of maximum heart rate) provides optimal benefit.

Resistance Training Considerations

Role: Complements aerobic activity; limited direct evidence for lipid/BP effects alone
Recommendation: Use 2 sessions/week of resistance training for general health and strength
Integration: Combine with aerobic activity for comprehensive fitness benefits
Progression: Gradual increase in weight/intensity over weeks
Caution: Avoid Valsalva maneuver; maintain steady breathing

Summary of Key Recommendations

This table consolidates the primary Class I and IIa recommendations from the guideline, organized by therapeutic area.

Intervention	Target/Details	Class	Level of Evidence	Expected Benefit
Dietary Pattern	Mediterranean or DASH: vegetables, fruits, whole grains, lean proteins, nuts, nontropical oils	I	A	LDL-C ↓ 10–15%, BP ↓ 8–14 mm Hg
Saturated Fat	5–6% of total daily calories	I	A	LDL-C ↓ 5–10%
Trans Fat	Minimize; avoid partially hydrogenated oils	I	A	LDL-C ↓, TG ↓
Sodium Intake	<2,400 mg/day; optimal 1,500 mg/day	I (≤2,400) IIa (1,500)	A	BP ↓ 2–8 mm Hg per 1,000 mg reduction
DASH + Sodium Reduction	Combined strategy for BP control	I	A	BP ↓ 13–20 mm Hg SBP
Aerobic Activity (Lipids)	3–4 sessions/week, 40 min/session, moderate-vigorous intensity	IIa	A	LDL-C ↓, HDL-C ↑, TG ↓
Aerobic Activity (BP)	3–4 sessions/week, 40 min/session, moderate-vigorous intensity	IIa	A	BP ↓ 2–5 mm Hg SBP, 1–4 mm Hg DBP
Weight Management	Maintain BMI 18.5–24.9 kg/m²	I	C	Improves BP, lipids, glucose tolerance
Alcohol Moderation	Men: ≤2 drinks/day; Women: ≤1 drink/day	IIa	B	BP control, overall CVD risk reduction

Related Risk Assessment Calculators

Use these evidence-based calculators to assess cardiovascular risk, monitor treatment goals, and guide lifestyle intervention intensity.

ASCVD Risk Calculator

Estimate 10-year and lifetime atherosclerotic cardiovascular disease risk

Framingham Risk Score

10-year cardiovascular disease risk assessment

PREVENT Calculator

Personalized prevention strategy for CVD risk reduction

SCORE2

European cardiovascular risk assessment tool

Lifetime ASCVD Risk

Assess long-term cardiovascular risk to age 90

MESA Risk Score

CVD risk prediction using imaging data

Disclaimer: This quick reference is intended as an educational tool for healthcare professionals. Always consult the full 2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk and apply clinical judgment in individual patient care. Not all recommendations may apply to every patient.

Citation: Eckel RH, Jakicic JM, Ard JD, et al. 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63(25):2960–2984. DOI: 10.1016/j.jacc.2013.11.003

← Back to Guidelines